ScienceHello,
Welcome to Insider
- AstraZeneca may have provided outdated information on its coronavirus shot, US health authorities said;
- A vaccine that can be taken as a pill could begin early clinical trials soon;
- 1 million people are flying out of US airports every day.
If you're new to this newsletter, sign up here. Tips and opinions about Google-Amazon-Microsoft-Apple in healthcare? Email me at bdodge@insider.com or tweet @dodgeblake.
AstraZeneca may have used outdated data in its US vaccine trial results, giving an 'incomplete view' of how well the shot worked, officials said
AstraZeneca may have included outdated data in its promising US vaccine trials results, officials said.- An independent expert panel was "concerned" that AstraZeneca gave an "incomplete view of the efficacy data."
- AstraZeneca said Monday its shot was 79% effective against preventing COVID-19 with symptoms.
Early tests are planned for a COVID-19 vaccine that can be taken as a pill, with no need for injections
- A
coronavirus vaccine in pill form could start human trials in June after producing antibodies in animals. - The Israeli-American company Oramed and the Indian company Premas Biotech are working on the pill.
- It has a long way to go, but could be easier to distribute than shots.
For 11 days in a row, more than 1 million people have flown from US airports, despite the CDC urging people not to travel
- The TSA screened more than 1.53 million passengers on Sunday, the most in more than a year.
- Flyers departing from US airports have topped 1 million for 11 days in a row.
- Airfares are hitting record lows as airlines try to lure flyers back during the vaccine push.
More stories we're reading today:
- Krispy Kreme will give a free doughnut a day to anyone with a COVID-19 vaccination card (Insider)
- Stop telling people not to travel. Health officials should be teaching us how to do it safely. (Insider)
- Covid cases are still rising by at least 5% in 27 states, per 7-day averages (CNBC)
- Blake